(Q34107868)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11122839%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Hodgkin's disease: prognostic factors and short-course regimens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11122839%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11122839%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

S M Arackal

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11122839%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11122839%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Current Oncology Reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11122839%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11122839%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11122839%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

163-171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11122839%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11912-000-0089-6

2 November 2019

exact match

0 references

cites work

Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-000-0089-6

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

12 December 2020

Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease: implications for different pathogenic mechanisms

1 reference

12 December 2020

Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease

1 reference

12 December 2020

Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.

1 reference

12 December 2020

Autotransplantation for relapsed or refractory Hodgkin's disease: long-term follow-up and analysis of prognostic factors

1 reference

12 December 2020

Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse

1 reference

12 December 2020

Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression.

1 reference

12 December 2020

Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized Hodgkin disease and unfavorable prognostic features: A phase II Cancer and Leukemia Group B Study (9051)

1 reference

12 December 2020

Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease

1 reference

12 December 2020

Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.

1 reference

12 December 2020

Classical Hodgkin's disease. Clinical impact of the immunophenotype

1 reference

12 December 2020

Prognostic factors in advanced Hodgkin's disease--can they guide therapeutic decisions?

1 reference

12 December 2020

Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease.

1 reference

12 December 2020

Who are the high-risk patients with Hodgkin's disease?

1 reference

12 December 2020

Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival

1 reference

12 December 2020

Hodgkin's disease: complications of therapy and excess mortality

1 reference

12 December 2020

Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report

1 reference

12 December 2020

Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome.

1 reference

12 December 2020

Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update

1 reference

12 December 2020

High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.

1 reference

12 December 2020

Are activated cytotoxic T cells in Hodgkin's disease biopsies a poor prognostic marker?

1 reference

12 December 2020

Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease

1 reference

12 December 2020

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

12 December 2020

Activated cytotoxic T cells as prognostic marker in Hodgkin's disease.

1 reference

12 December 2020

Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group.

1 reference

12 December 2020

Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients.

1 reference

12 December 2020

Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?

1 reference

12 December 2020

Autologous stem cell transplantation as adjuvant treatment vs no further therapy for poor-risk Hodgkin's disease in first complete remission after MOPP/ABVD.

1 reference

12 December 2020

Prognosis of patients with advanced Hodgkin's disease: evaluation of four prognostic models using 344 patients included in the Group d'Etudes des Lymphomes de l'Adulte Study

1 reference

12 December 2020